AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 63 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 4.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $195 | -19.4% | 25,050 | 0.0% | 0.00% | -33.3% |
| Q2 2023 | $242 | -49.8% | 25,050 | -43.0% | 0.01% | -25.0% |
| Q1 2023 | $482 | -99.6% | 43,952 | +339.5% | 0.01% | +166.7% |
| Q1 2022 | $124,000 | -84.6% | 10,000 | -71.6% | 0.00% | -87.0% |
| Q4 2021 | $805,000 | +357.4% | 35,200 | +12.5% | 0.02% | +109.1% |
| Q2 2018 | $176,000 | +8.6% | 31,300 | 0.0% | 0.01% | +10.0% |
| Q1 2018 | $162,000 | – | 31,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Berry Street Capital Management LLP | 1,987,500 | $24,605,000 | 2.79% |
| NEA Management Company, LLC | 3,969,834 | $49,146,000 | 1.42% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 133,117 | $1,648,000 | 0.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 435,000 | $3,955,000 | 0.89% |
| ACT CAPITAL MANAGEMENT, LLC | 67,500 | $836,000 | 0.88% |
| Artal Group S.A. | 1,000,000 | $12,380,000 | 0.52% |
| CTC Capital Management, LLC | 12,800 | $158,000 | 0.42% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 581,910 | $7,204,000 | 0.36% |
| Affinity Asset Advisors, LLC | 175,000 | $2,167,000 | 0.35% |
| Bellevue Group AG | 2,405,825 | $29,784,000 | 0.35% |